factually
Index/Topics/Androgen-deprivation therapy (ADT) for prostate cancer

Androgen-deprivation therapy (ADT) for prostate cancer

The use of androgen-deprivation therapy (ADT) in addition to salvage radiotherapy (SRT) for patients with biochemical recurrence (BCR) after radical prostatectomy, particularly those with high-risk features.

Fact-Checks

1 result
Jan 11, 2026
Most Viewed

When should androgen‑deprivation therapy be added to salvage radiotherapy after prostatectomy?

Androgen‑deprivation therapy (ADT) should be added to salvage radiotherapy (SRT) after radical prostatectomy when biochemical recurrence (BCR) is accompanied by high‑risk features—most guidelines and ...